⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | ICICI Prudential Innovation Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹19.09 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Vaibhav Dusad | Nikhil Mathur |
| Inception | 28 Apr 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | -2.62% | 22.64% |
| 3Y | 18.46% | 30.41% |
| 5Y | — | — |
| Since Inception | 20.64% | 29.15% |
| Risk | ||
| 13.71 | 14.07 | |
| 0.94 | 0.59 | |
| 0.85 | 1.59 | |
| 7.97 | 21.67 | |
| 1.63 | 3.48 | |
| -10.64% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.24% | 1.03% |
| Exit Load | 1% on or before 1M, Nil after 1M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
ICICI Prudent…94%
HDFC MF94%
5.7%Only 5.7% of holdings by weight are common between ICICI Prudential Innovation Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingICICI Prudential Innovation Fund - Growth - Direct PlanHDFC MF
Dr. Reddy's Laboratories Ltd.2.11%3.19%
Divi's Laboratories Ltd.1.92%9.39%
Apollo Hospitals Enterprise Ltd.1.67%3.69%
Category context: Equity vs Equity. Open the full Screener →